Tick saliva contains a number of effector molecules that inhibit host immunity and facilitate pathogen transmission. How tick proteins regulate immune signaling, however, is incompletely understood. Here, we describe that loop 2 of sialostatin L2, an anti-inflammatory tick protein, binds to annexin A2 and impairs the formation of the NLRC4 inflammasome during infection with the rickettsial agent Anaplasma phagocytophilum. Macrophages deficient in annexin A2 secreted significantly smaller amounts of interleukin-1␤ (IL-1␤) and IL-18 and had a defect in NLRC4 inflammasome oligomerization and caspase-1 activation. Accordingly, Annexin a2-deficient mice were more susceptible to A. phagocytophilum infection and showed splenomegaly, thrombocytopenia, and monocytopenia. Providing translational support to our findings, better binding of annexin A2 to sialostatin L2 in sera from 21 out of 23 infected patients than in sera from control individuals was also demonstrated. Overall, we establish a unique mode of inflammasome evasion by a pathogen, centered on a blood-feeding arthropod.
T icks are obligate blood-feeding arthropods that transmit a multitude of infectious agents, including viruses, bacteria, fungi, protozoa, and helminths (1) (2) (3) . Pathogen transmission occurs during the uptake of a blood meal, when ticks inject saliva into the mammalian host, affecting hemostasis and host immune responses (1) (2) (3) . Tick saliva contains an arsenal of molecules with antihemostatic, anesthetic, and anti-inflammatory properties (4) (5) (6) . How tick salivary proteins manipulate the activity of the inflammasome remains mostly elusive. Inflammasomes are complex structures that orchestrate the maturation of the proinflammatory cytokines interleukin-1␤ (IL-1␤) and IL-18 (7) (8) (9) . Inflammasomes are categorized according to their cognate Nod-like receptor (NLR) member and lead to the activation of caspase-1 and -11 (caspase-4 in humans) (7) (8) (9) . Activated caspase-1 then processes pro-IL-1␤ and pro-IL-18 into their mature forms (7) , promoting host defenses through complex pleiotropic mechanisms (7) (8) (9) .
The NLRC4 inflammasome is activated in response to components of the bacterial type III secretion system and flagellin (8) (9) (10) (11) . To sense virulent bacteria, NLRC4 cooligomerizes with ancillary molecules referred to as NAIPs (neuronal apoptosis inhibitory proteins) (8, 9) . NAIP5 and NAIP6 directly bind flagellin, whereas NAIP2 and NAIP1 (human NAIP) recognize the bacterial type III secretion system rod and the needle protein that trigger NLRC4 activation (12) (13) (14) (15) . Previously, we demonstrated that the tick salivary protein sialostatin L2 targets inflammasome activity during host stimulation with the rickettsial bacterium Anaplasma phagocytophilum, the causative agent of human granulocytic anaplasmosis (16) . Which protein was binding to sialostatin L2 and whether this molecule affected inflammasome activation during rickettsial infection remained unclear.
In this report, we reveal that sialostatin L2 impairs the for-mation of the NLRC4 inflammasome during rickettsial infection. The inhibition of NLRC4 inflammasome activity occurs because sialostatin L2 tethers to the phospholipid binding protein annexin A2 in both animal models and patients, hence blocking NLRC4 inflammasome oligomerization, caspase-1 activation, and IL-1␤ and IL-18 secretion. Given the importance of the inflammasome for pathogen recognition, our findings provide a novel facet for the understanding of arthropodborne diseases. (17, 18) . Mice were gender matched and at least 6 to 10 weeks of age. Bone marrow-derived macrophages (BMDMs) were generated as previously described (16) . Culturing of A. phagocytophilum strain HZ and calculations were described previously (16) . Both Salmonella enterica serovar Typhimurium strain SL1344 and the Francisella tularensis live vaccine strain (LVS) were a gift from Stefanie Vogel at the University of Maryland, Baltimore, School of Medicine. Francisella LVS bacteria were grown on cysteine heart agar (Difco) supplemented with 5% horse blood cells at 37°C. Isolates were inoculated in Mueller-Hinton broth (Difco) supplemented with 2% (wt/vol) IsoVitaleX, 1% (wt/vol) glucose, and 0.25% (wt/vol) ferric pyrophosphate. Salmonella bacteria were grown in HS medium at 37°C and enumerated as previously described (19) .
MATERIALS AND METHODS
Patients. Human clinical serum samples were obtained over a range of years from 1994 through 2013 under Institutional Review Board (IRB) protocols approved at the Duluth Clinic (Minnesota) and through IRBapproved exemptions for their use at the University of Maryland, Baltimore, School of Medicine and The Johns Hopkins University School of Medicine (approval number 01-03-26-04e). Samples approved at the Duluth Clinic required consent to obtain serum and blood during the acute and the convalescent phases of infection. The IRB protocol was registered under the protocol "Molecular and Antigenic Study of a Novel Human Ehrlichia" on 11 February 1994. The second protocol was approved under an exempt status by the University of Maryland, Baltimore, School of Medicine on 21 February 1994 for the use of the prospectively obtained samples from the Duluth Clinic. The third protocol was approved by The Johns Hopkins University School of Medicine in January 1996 and received an exemption from the Joint Committee on Clinical Investigation.
Chemical reagents. Lipopolysaccharide (LPS) was purchased from InvivoGen. Nigericin and ATP were purchased from Sigma-Aldrich. Recombinant human annexin A2 was purchased from Abcam and Novus Biologicals. Bovine serum albumin (BSA) was purchased from New England BioLabs.
Sialostatin L2 cloning, protein expression, peptides, and antibodies. Full-length sialostatin L2 from the tick Ixodes scapularis was amplified by PCR from the clone pET-17b-Sialostatin L2 with forward (Fwd) primer 5=-GGCCGGATCCGAACTGGCTCTGCGTGGTGG-3= and reverse (Rev) primer 5=-GGCCCTCGAGTTTATGCGGCCGCACACT CAA-3= containing BamHI and XhoI sites, respectively (underlined). The amplicon was digested and cloned into pGEX-6-P2 (GE Healthcare). Results of sequencing analysis were verified by using pGEX primers (Fwd primer 5=-GGGCTGGCAAGCCACGTTTGGTG-3=/Rev primer 5=-CCG GGAGCTGCATGTGTCAGAGG-3=) at the University of Maryland, Baltimore, Biopolymer Core Facility. A glutathione S-transferase (GST)-sialostatin L2 fusion protein was induced and purified in Escherichia coli BL21(DE3) cells. Endotoxin-free recombinant sialostatin L2 (rSL2) and the three sialostatin L2 peptides were produced as previously described (16) . The amino acid sequences of the three synthesized peptides were (i) ELALRGGYRERSNQDDPEY for the N terminus, (ii) SAQQPGKTHFD TVVEVLKVETQTVAGT for loop 1, and (iii) TCELTSTYNKDTCQANA NAAQRTCTTVIYRNLQGEKSISSFECAA for loop 2. Peptide synthesis and folding were performed by an external contractor (SynBioSci Corporation).
GST or the recombinant GST-sialostatin L2 proteins were purified by using GST-Bind resin (Thermo Scientific) according to the manufacturer's instructions. Purified proteins were dialyzed with 10 mM Tris-HCl buffer (pH 7.5) using SnakeSkin dialysis tubing (3,500-molecular-weight [3.5K] cutoff; Thermo Scientific) and were concentrated with centrifuge filter units (3K cutoff; Amicon). The protein concentration was determined by using the bicinchoninic acid (BCA) assay (Thermo Scientific).
Sialostatin L2 mouse monoclonal and rabbit polyclonal antibodies were produced at the Institute of Parasitology, Biology Centre, Academy of Sciences of the Czech Republic. Sialostatin L2 rabbit polyclonal antibody was purified with a Melon Gel IgG Spin Purification kit (Thermo Scientific). Normal rabbit IgG was purchased from Santa Cruz. For the monoclonal sialostatin L2 antibody, a BALB/c mouse was immunized intraperitoneally with three doses containing 10 g each of sialostatin L2 14 days apart. The first dose was administered with complete Freund's adjuvant (Sigma), the second was administered with incomplete Freund's adjuvant (Sigma), and the third was administered without adjuvant 3 days before fusion. Spleen cells were fused with Sp2/0 myeloma cells by using polyethylene glycol (Sigma). Hybridoma cells were cloned by a limiting-dilution technique. Antibodies in hybridoma culture medium were detected by an indirect enzyme-linked immunosorbent assay (ELISA). Monoclonal antibodies were purified from culture medium by using a Montage antibody purification kit with Prosep-A medium (Millipore).
GST pulldown assays. A total of 1.25 nM GST or GST-sialostatin L2 was incubated with equilibrated GST-Bind resin (Thermo Scientific) for 1 h at 4°C. After five washes with the GST binding/washing buffer (25 mM Tris and 150 mM NaCl [pH 7.3]), the resin was incubated with 1 mg of BMDM lysates infected with A. phagocytophilum for 1 h at 4°C. Following seven washes with modified GST binding/washing buffer containing 200 mM NaCl, the protein complexes were cleaved from GST resin with GST PreScission protease (GE HealthCare). Eluates were identified by the proteomics facility of the University of Maryland, Baltimore, School of Pharmacy.
Native polyacrylamide gel electrophoresis. Equal amounts of supernatants were mixed with native sample buffer (62.5 mM Tris-HCl, 40% glycerol, 0.01% bromophenol blue [pH 6.8]), loaded into 4 to 15% Mini-Protean TGX precast gels, and run at 200 V for 2 h in 1ϫ Tris-glycine native running buffer (25 mM Tris, 192 mM glycine [pH 8.3]). A Native-Mark unstained protein standard (Invitrogen) was visualized with Gel Code Blue Safe Protein Stain solution (Thermo Scientific).
Immunoblotting. Cell lysates were prepared in radioimmunoprecipitation assay (RIPA) lysis buffer (Boston Bioproducts) with Halt protease inhibitor cocktail (Thermo Scientific) and PhosSTOP (Roche Applied Science). Four percent to 15% Mini-Protean TGX precast gels were run at 200 V for 30 min in 1ϫ Tris-glycine-SDS running buffer (Boston Bioproducts). Transfer was performed by using Bio-Rad Trans-Blot Turbo with either polyvinylidene difluoride (PVDF) or nitrocellulose membranes (Bio-Rad). Membranes were blocked in 5% skim milk or BSA (Bio-Rad). Western blot antibodies for caspase-1 ELISAs and binding assays. IL-1␤ and IL-6 levels were measured with the BD OptEIA set (BD Biosciences). IL-18 capture (1:1,000) (catalog number D047-3) and detection (1:2,000) (catalog number D048-6) antibodies were purchased from MBL. For binding assays, C57BL/6 BMDMs were lysed in RIPA buffer supplemented with Halt protease inhibitor cocktail (Thermo Scientific) and PhosSTOP (Roche Applied Science). Ninety-six-well plates were coated with 0.5 g of the cell lysate resuspended in 0.5 M carbonate-bicarbonate (pH 9.5) at 4°C overnight. Plates were washed (1ϫ phosphate-buffered saline [PBS], 0.05% Tween 20) and blocked with assay diluent (1ϫ PBS, 10% heat-inactivated fetal bovine serum [FBS]) for 1 h at room temperature, followed by incubation with the polyclonal sialostatin L2 antibody (1:200) and the goat anti-rabbit IgG-HRP-conjugated antibody (1:10,000) (Abcam). A 1:1 mixture of the 3,3=,5,5=-tetramethylbenzidine (TMB) substrate (BD Biosciences) was made and added to each well. Plates were incubated for up to 30 min before the reaction was stopped with 1 M H 2 SO 4 . The Bio-Rad iMark reader was used to measure the absorbance at 450 nm with a 595-nm correction.
To detect the binding specificity of the sialostatin L2 monoclonal or polyclonal antibody, 0.2 g of the recombinant sialostatin L2 protein was coated in 0.5 M carbonate-bicarbonate coating buffer and incubated with antibodies at the indicated concentrations. For the detection of protein interactions, C57BL/6 and Annexin a2 Ϫ/Ϫ BMDMs treated with A. phagocytophilum (multiplicity of infection [MOI] of 50) were lysed as described above and incubated with different titrations of mouse sialostatin L2 monoclonal antibody with 5 M sialostatin L2 for 2 h at room tempera-ture. The rabbit affinity-purified sialostatin L2 polyclonal antibody (1: 200) and goat anti-rabbit IgG-HRP (1:10,000; Abcam) were used for the detection of protein complexes. In the converse binding experiments, annexin A2 polyclonal antibody derived from goat (1:200; Thermo Scientific) and donkey anti-goat IgG-HRP (1:10,000; Abcam) were used.
Quantitative RT-PCR. Genomic DNA from mice was isolated with a DNeasy blood and tissue kit (Qiagen). Quantitative reverse transcription-PCR (RT-PCR) was performed by using Power SYBR green PCR master mix (Invitrogen) in an ABI 7500 real-time PCR instrument. Primer sequences for A. phagocytophilum were as follows: 16S-F (5=-CAGCCACA CTGGAACTGAGA-3=) and 16S-R (5=-CCCTAAGGCCTTCCTCACTC-3=). Gene expression was normalized by using primers ␤-actin-F (5=-ACGCAGAGGGAAATCGTGCGTGAC-3=) and ␤-actin-R (5=-ACGCG GGAGGAAGAGGATGCGGCAGTG-3=). The absolute quantification method was used.
Mobility shift electrophoresis. A total of 0.2 g of annexin A2 was mixed with different amounts of recombinant sialostatin L2 as indicated, followed by native PAGE and immunoblotting assays with the anti-an- nexin A2 mouse monoclonal antibody (1:500; Protein Tech) and goat anti-mouse HRP (1:5,000; Abcam). A total of 1.0 g of recombinant sialostatin L2 was mixed with different amounts of either C57BL/6 or Annexin a2-deficient BMDM lysates.
Structural docking analysis. Docking of sialostatin L2 (PDB accession number 3LH4) into the human annexin A2 protein (PDB accession number 2HYW) was performed by using the programs GRAMMX (20) and ZDOCK 3.0.2 (21) . All residues were included in docking algorithms with no bias defined for either crystal structure. The program PyMOL (22) was used to generate a cartoon representation of the docked structures.
In vivo infection. C57BL/6 (n ϭ 20) and Annexin a2 Ϫ/Ϫ (n ϭ 11) mice were infected by intraperitoneal injection with A. phagocytophilum strain HZ (1 ϫ 10 7 cells). Blood samples were collected at days 0, 5, and 10 for the IL-18 ELISA. Spleens were removed, normalized to body weight, and compared to those of noninfected mice. Spleens were fixed at day 15 postinfection with 10% neutral buffered formalin and embedded in paraffin wax. Sections (5 m) were obtained and stained with hematoxylin and eosin. Measurement of the A. phagocytophilum load was done at day 5 postinfection in the peripheral blood of infected animals by using quantitative RT-PCR, as described above. Numbers of platelets and monocytes were measured at day 15 postinfection in a commercial laboratory (Antech Diagnostics).
Statistical analysis. All experiments in this study were performed with at least 2 to 5 replicates. All data were expressed as means Ϯ standard errors of the means (SEM). The differences between groups were examined by either unpaired Student's t test or one-way analysis of variance (ANOVA). All statistical calculations and graphs were made by using GraphPad Prism version 6.0. A P value of Ͻ0.05 was considered statistically significant.
RESULTS AND DISCUSSION
The NLRC4 inflammasome is activated during A. phagocytophilum infection. We previously reported that mice deficient in Nlrc4 and Caspase-1/11 are susceptible to A. phagocytophilum infection (17) . To provide support for this concept, we first stimulated unprimed murine bone marrow-derived macrophages (BMDMs) with A. phagocytophilum. Wild-type macrophages secreted IL-1␤ and IL-18 upon stimulation ( Fig. 1A and B ), while Nlrc4 Ϫ/Ϫ and Caspase-1/11 Ϫ/Ϫ macrophages exhibited severe defects in IL-1␤ and IL-18 release ( Fig. 1A and B ). As expected, secretion of IL-6 and translation of IL-1␤ and IL-18 by macrophages, which are not regulated by the inflammasome, remained unaffected (Fig. 1C to E). Oligomerization of the inflammasome (Fig. 1D ) and caspase-1 autoproteolysis (Fig. 1E) were hindered in the absence of NLRC4 and caspase-1. Caspase-11, the noncanonical inflammasome enzyme that recognizes LPS in cytosolic bacteria (7) , was dispensable for cytokine release or inflammasome oligomerization upon A. phagocytophilum colonization of macrophages ( Fig. 1A to D) . Collectively, we detected endogenous NLRC4 inflammasome oligomerization in macrophages upon A. phagocytophilum stimulation. Although native inflammasome immunoblots were previously described (13, 15, 23) , those studies used the HEK293T cell reconstitution system. We also provided strong evidence that the NLRC4 inflammasome in macrophages is critical for sensing A. phagocytophilum infection in the mammalian host. This was con- sistent with previous work correlating disease outcome with classical macrophage activation in both animal models and patients (16, (24) (25) (26) .
Annexin A2 binds to the tick salivary protein sialostatin L2. Next, we demonstrated that in the presence of the tick salivary molecule sialostatin L2, A. phagocytophilum colonization of macrophages resulted in reduced caspase-1 activity and inflammation (16) , suggesting that sialostatin L2 may interfere with the A. phagocytophilum-induced inflammasome. Here, macrophages were pretreated with recombinant sialostatin L2 (rSL2) prior to A. phagocytophilum colonization. rSL2 blocked NLRC4 oligomerization, and this effect was reversed when an anti-sialostatin L2 IgGpurified polyclonal antibody bound to rSL2 before macrophage exposure to this pathogen ( Fig. 2A) . We then used an unbiased pulldown assay followed by mass spectrometry and discovered that the phospholipid binding protein annexin A2 strongly bound to rSL2. To confirm these findings, we coincubated recombinant annexin A2 with rSL2 and performed mobility shift electrophoresis. The mobility of annexin A2 was shifted with increasing amounts of rSL2 (Fig. 2B) . These results were substantiated by an ELISA-based assay (Fig. 2C) . The binding of annexin A2 to rSL2 occurred regardless of which molecule was surface immobilized on the ELISA plate (see Fig. S1 in the supplemental material). Furthermore, the interaction of annexin A2 and rSL2 was blocked by a sialostatin L2-specific monoclonal antibody (see Fig. S2 in the supplemental material). The sialostatin L2 monoclonal antibody inhibited the binding of rSL2 to annexin A2 in a dose-dependent manner (Fig. 2D) .
To validate these biochemical interactions, we prepared wildtype and Annexin a2 Ϫ/Ϫ macrophages. rSL2 bound poorly to Annexin a2 Ϫ/Ϫ macrophage lysates compared to wild-type cells, as judged by native gels and ELISAs ( Fig. 2E and F) . Finally, we per- formed structural docking of sialostatin L2 to annexin A2 and predicted that loop 2, but not loop 1 or the N terminus of sialostatin L2, binds to annexin A2 (Fig. 3A) . This model was experimentally verified by using peptides specific for each protein region. Only loop 2 of sialostatin L2 was bound to annexin A2 (Fig. 3B ).
There is increasing evidence suggesting that the disease caused by A. phagocytophilum in patients is more complex than that in model systems (27) . To provide translational relevance to our research findings, we determined whether rSL2 bound to human annexin A2 in a pathophysiological setting. We obtained sera from 23 acutely infected patients and compared the results to those for sera from 11 control individuals. Annexin A2 bound better to rSL2 in the sera of 21 out of 23 A. phagocytophilum-infected patients than in the sera of control individuals (Fig. 4) .
Annexin A2 regulates the NLRC4 inflammasome pathway upon A. phagocytophilum infection. Subsequently, we investigated whether Annexin a2 Ϫ/Ϫ macrophages had a defect in IL-1␤ and IL-18 secretion upon A. phagocytophilum colonization. Wildtype macrophages secreted significantly larger amounts of IL-1␤ and IL-18 at multiplicities of infection (MOI) of 10 and 50 than did Annexin a2 Ϫ/Ϫ cells ( Fig. 5A and B ). This effect did not appear to be a global cytokine defect because there was no measurable difference in IL-6 levels between wild-type and Annexin a2 Ϫ/Ϫ macrophages (Fig. 5C ). Annexin a2 Ϫ/Ϫ macrophages were also defective for caspase-1 activation and NLRC4 oligomerization ( Fig. 5D and E) . In contrast, Annexin a2 Ϫ/Ϫ macrophages secreted IL-1␤, IL-18, and IL-6 at wild-type levels when infected with Salmonella, a canonical NLRC4 agonist ( Fig. 6A to C) . Comparable results were also obtained with the NLRP3 agonists ATP and ni- gericin and the AIM2 stimulant Francisella (Fig. 6A to F) . Not surprisingly, Myd88 Ϫ/Ϫ macrophages exhibited defects in all parameters measured (Fig. 6A to F) . Furthermore, Salmonella, Francisella, ATP, and nigericin induced inflammasome oligomerization independently of annexin A2 (Fig. 6G) . Overall, we discovered that the signaling cascade that regulates the A. phagocytophilum-induced inflammasome is fundamentally different from other protein scaffolds, as annexin A2 was necessary for NLRC4 oligomerization upon A. phagocytophilum infection. Conversely, the assembly of canonical inflammasomes, here represented by the agonists Salmonella, Francisella, ATP, and nigericin, occurred regardless of the presence of annexin A2.
Annexin A2 deficiency renders susceptibility to A. phagocytophilum infection. To evaluate the biological impact of these biochemical interactions in vivo, we infected mice deficient in annexin A2 with A. phagocytophilum. Compared to Nlrc4 Ϫ/Ϫ and Caspase-1/11 Ϫ/Ϫ mice (17) , Annexin a2 Ϫ/Ϫ animals were suscep-tible to A. phagocytophilum infection (Fig. 7A) . Moreover, mice deficient in annexin A2 showed a reduced release of IL-18 secretion in the peripheral blood compared to the wild-type genotype (Fig. 7B) . These findings were consistent with our previous reports showing that IL-18 release mediated by the NLRC4 inflammasome regulates IFN-␥ production by CD4 ϩ T cells upon A. phagocytophilum infection (17) .
The A. phagocytophilum mouse model is characterized by splenomegaly and mild to severe inflammatory splenic histopathology (28) . Annexin a2 Ϫ/Ϫ mice revealed enlarged spleens compared to those of control animals ( Fig. 7C and D) . Annexin a2 Ϫ/Ϫ animals also had increased cellular infiltration in the red pulp and damage to the splenic architecture upon A. phagocytophilum infection (Fig. 7E) . Concurrently, thrombocytopenia and monocytopenia, two commonly observed clinical presentations during A. phagocytophilum infection (27) , ensued in Annexin a2 Ϫ/Ϫ mice ( Fig. 7F and G) . In summary, we demonstrate in this report that (i) annexin A2 regulates the formation of the NLRC4 inflammasome during A. phagocytophilum infection, (ii) annexin A2 is critically important for A. phagocytophilum infection in vivo, (iii) sialostatin L2 binds to annexin A2 in both mice and humans, and (iv) sialostatin L2 inhibits the activation of mouse NLRC4 inflammasome formation upon rickettsial infection. The implications for these findings are wide in scope, as ticks, mosquitoes, biting flies, fleas, and blood-feeding bugs secrete salivary proteins for modulating host defenses. Intriguingly, our report also suggests the possibility that an alternative signaling cascade for the inflammasome may exist, because unlike Salmonella, A. phagocytophilum does not have the NLRC4 canonical activators (29) .
